Found 5 Enz. Inhib. hit(s) with all data for entry = 7627 TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Xenon Pharmaceuticals
US Patent
Xenon Pharmaceuticals
US Patent
Affinity DataIC50: 3nMAssay Description:The assay is based on the guanidine influx assay described by Reddy, N.
L., et al., J. Med. Chem. (1998), 41(17):3298-302. The guanidine influx
ass...More data for this Ligand-Target Pair
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Xenon Pharmaceuticals
US Patent
Xenon Pharmaceuticals
US Patent
Affinity DataIC50: 5nMAssay Description:The assay is based on the guanidine influx assay described by Reddy, N.
L., et al., J. Med. Chem. (1998), 41(17):3298-302. The guanidine influx
ass...More data for this Ligand-Target Pair
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Xenon Pharmaceuticals
US Patent
Xenon Pharmaceuticals
US Patent
Affinity DataIC50: 7nMAssay Description:The assay is based on the guanidine influx assay described by Reddy, N.
L., et al., J. Med. Chem. (1998), 41(17):3298-302. The guanidine influx
ass...More data for this Ligand-Target Pair
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Xenon Pharmaceuticals
US Patent
Xenon Pharmaceuticals
US Patent
Affinity DataIC50: 15nMAssay Description:The assay is based on the guanidine influx assay described by Reddy, N.
L., et al., J. Med. Chem. (1998), 41(17):3298-302. The guanidine influx
ass...More data for this Ligand-Target Pair
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Xenon Pharmaceuticals
US Patent
Xenon Pharmaceuticals
US Patent
Affinity DataIC50: 4.20E+3nMAssay Description:The assay is based on the guanidine influx assay described by Reddy, N.
L., et al., J. Med. Chem. (1998), 41(17):3298-302. The guanidine influx
ass...More data for this Ligand-Target Pair
